Acute tryptophan depletion in schizophrenia

Psychological Medicine

Volumn 31, Issue 1, 2001, Pages 75-84

  Golightly, K L ^a   Lloyd, J A ^a   Hobson, J E ^a   Gallagher, P ^a   Mercer, G ^a   Young, A H ^a,b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMISULPRIDE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOZAPINE; DEXFENFLURAMINE; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; FLUOXETINE; FLUVOXAMINE; LYSERGIDE; NEUROLEPTIC AGENT; NEUROTRANSMITTER; OLANZAPINE; PAROXETINE; PSYCHEDELIC AGENT; QUETIAPINE; RISPERIDONE; RITANSERIN; SEROTONIN; SEROTONIN 2 ANTAGONIST; SEROTONIN 2 RECEPTOR; SEROTONIN AGONIST; SEROTONIN RECEPTOR; SEROTONIN UPTAKE INHIBITOR; SERTINDOLE; SERTRALINE; TRYPTOPHAN; TYROSINE; UNINDEXED DRUG;

ADULT; ARTICLE; ATTENTION; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEPLETION; DISEASE CLASSIFICATION; DOUBLE BLIND PROCEDURE; DRINKING; DRUG MECHANISM; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MALE; MEMORY; MENTAL PERFORMANCE; MOOD; MOTOR DYSFUNCTION; PATHOPHYSIOLOGY; PATIENT SELECTION; PSYCHIATRIC DIAGNOSIS; PSYCHOLOGIC ASSESSMENT; RATING SCALE; SCHIZOPHRENIA; SYMPTOMATOLOGY; TRYPTOPHAN METABOLISM;

ADMINISTRATION, ORAL; ADULT; AFFECT; AMINO ACIDS; BLOOD-BRAIN BARRIER; COGNITION; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PROTEIN BIOSYNTHESIS; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; TRYPTOPHAN;

EID: 0035164314     PISSN: 00332917     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0033291799003062     Document Type: Article

References (41)

1. Enhancement of the prolactin response to d-fenfluramine in drug-naïve schizophrenic patients
2. A rating scale for drug-induced akathisia
3. Neurotransmitter receptors in frontal cortex of schizophrenics
4. Tryptophan depletion during continuous CSF sampling in healthy human subjects
5. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients
6. Effects of 8-OH-DPAT or SR 57746A long-term treatment combined with muscarinic blockade on spatial memory in the rat
7. Effect of clozapine on d-fenfluramine-evoked neuroendocrine responses in schizophrenia and its relationship to clinical improvement
8. Serotonin function and the mechanism of antidepressant action; reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan
9. Ritanserin, a selective 5-HT2/1C antagonist and negative symptoms in schizophrenia. A placebo-controlled double-blind trial
10. Antagonism between lysergic acid diethylamide and 5-hydroxytryptamine
11. Serotonin function and treatment response to clozapine in schizophrenic patients
12. The positive and negative syndrome scale (PANSS) for schizophrenia
13. Dissociation of ketamine effects on rule acquisition and rule implementation: Possible relevance to NMDA receptor contributions to executive cognitive functions
14. Test/re-test reliability of the CANTAB and ISPOCD neuropsychological batteries: Theoretical and practical issues
15. Whole blood serotonin and plasma tryptophan using high-pressure liquid chromatography with electrochemical detection
16. The role of serotonin in antipsychotic drug action
17. The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia
18. 5-HT system and cognition
19. Acute tryptophan depletion: A method of studying antidepressant action
20. Tryptophan depletion in normal volunteers produces selective impairments in learning and memory
21. Multiple serotonin receptors: Differential binding of [3H] 5-hydroxytryptamine, [3H] lysergic acid diethylamide and [3H] spiroperidol
22. Animal studies of dementia
23. Rapid depletion of plasma tryptophan: A review of studies and experimental methodology
24. Neuroleptic affinities for human brain receptors and their use in predicting adverse effects
25. Effect of a low-tryptophan diet as an adjuvant to conventional neuroleptic therapy in schizophrenia
26. Acute dietary tryptophan depletion: Effects on schizophrenic positive and negative symptoms
27. A rating scale for extrapyramidal side effects
28. A biochemical and pharmacological suggestion about certain mental disorders
29. Tryptophan depletion causes rapid lowering of mood in normal males
30. Biochemical aspects of tryptophan depletion in primates